Anika Therapeutics shares rise 1.04% intraday after Medtronic announces board appointments and strategic initiatives.

Anika Therapeutics, Inc. rose 1.04% in intraday trading. Medtronic plc, a global leader in healthcare technology, announced the appointment of John Groetelaars and Bill Jellison as independent directors, effective immediately. The company also formed new Growth and Operating committees to enhance focus on strategic portfolio management, operational execution, and capital allocation. These initiatives follow constructive engagement with Elliott Management and aim to create shareholder value.